INTRODUCTION
The fetal origins of health and disease framework, commonly referred to as the Barker hypothesis, 1 has identified extremes in fetal growth and birth weight as factors associated with the lifelong generation of several chronic diseases, including obesity, 2,3 type 2 diabetes, 4, 5 cardiovascular disease, 6, 7 and hypertension. 8 This hypothesis originally suggested that several chronic diseases of adulthood may result from abnormal programming in utero in response to undernutrition during pregnancy. 1 Since then, the Barker hypothesis has evolved to recognize that many environmental influences, in addition to maternal undernutrition, play pivotal roles in fetal development, birth weight, and subsequent adult disease risk. 9 Because the developing fetus is programmable, the intrauterine environment can influence the fetus's developmental trajectory. 10 Alterations can take place in the fetus itself or in the placenta, which is the vital organ of pregnancy and is responsible for exchange of nutrients and gas. 11 If the conditions of the intrauterine environment are not conducive to promoting optimal growth and development in later life, the lasting effects of developmental programming may predispose the offspring to chronic illness. 10 Environmental influences such as maternal stress, 12 smoking, 13, 14 and malnutrition, including overand undernutrition, 15, 16 may lead to changes in developmental programming. This narrative review aims to summarize the current knowledge on 1) the role of maternal dietary methyl donor intake in fetal growth and DNA methylation changes in the fetus and/or in the placenta and 2) the relationship between these dietinduced DNA methylation changes and fetal growth, development, and susceptibility to chronic diseases later in life.
ROLE OF DIETARY METHYL DONORS AND COFACTORS IN ONE-CARBON METABOLISM AND DNA METHYLATION
The diet provides molecules (methyl donors) required to modify the epigenome and, in turn, gene expression. 17 An individual's epigenome consists of changes around or above the DNA that do not affect the sequence of the DNA. 18 Epigenetics comprises different characteristics, such as methylation, histone modification, and noncoding RNA, which can regulate gene transcription. 18 For example, chemical tags are attached to the DNA (methyl groups) and/or histones (methyl and acetyl groups) of an individual's genome and can play a profound regulatory role dictating which genes will be expressed or silenced in a given cell, tissue type, or organ. 18 In one-carbon metabolism, nutrients from the diet provide methyl groups required for the process of DNA methylation ( Figure 1 ). Methyl-group donors involved in the one-carbon cycle, such as methionine, folate, and choline, as well as cofactors, including zinc and vitamins B 2 , B 6 , and B 12 , are derived entirely from diet (natural and fortified foods) and supplement intake. 19 This cycle consists of 2 methylation pathways, one folate-dependent and the other folate-independent, in which homocysteine is re-methylated to form methionine, which then generates S-adenosylmethionine (SAM), the universal methyl donor. 18 The resulting DNA methylation is cell and tissue-specific thereby contributing to the observed phenotypic differences. 20 Folic acid, the fully oxidized form of folate, is commonly used as a food fortificant and in vitamin supplements and plays a key role in the folate-dependent cycle, where it is reduced to dihydrofolate and eventually to tetrahydrofolate. 21 In the mitochondrial glycine cleavage system, the enzyme serine hydroxymethyltransferase catalyzes the reaction of serine to glycine and uses vitamin B 6 as a coenzyme in the conversion of tetrahydrofolate to 5,10-methylenetetrahydrofolate (5,10-MTHF). 22 Next, 5,10-MTHF is converted into 5-methyltetrahydrofolate (5-MTHF) by the enzyme methylenetetrahydrofolate reductase and cofactor flavin adenine dinucleotide, to which vitamin B 2 is a precursor.
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In contrast with folic acid, dietary folate enters the cycle as 5-MTHF, which transfers a methyl group to homocysteine to generate methionine and regenerate tetrahydrofolate. 23 This process uses methionine synthase and vitamin B 12 as a cofactor. 23 Betaine can be derived from choline or consumed directly from the diet and is key to the folate-independent cycle. In the folate-independent cycle, methionine is formed from homocysteine via the conversion of betaine to dimethylglycine by the enzyme betaine homocysteine methyltransferase in a reaction requiring zinc. 24 Methionine is converted into SAM, which supplies the methyl groups needed for DNA Figure 1 Dietary methyl donors and cofactors involved in one-carbon metabolism and DNA methylation. Abbreviations: BHMT, betaine homocysteine methyltransferase; CH 3 , methyl group; DHF, dihydrofolate; DHFR, dihydrofolate reductase; DMG, dimethylglycine; FAD, flavin adenine dinucleotide; MS, methionine synthase; MT, DNA methyltransferase; 5-MTHF, 5-methyltetrahydrofolate; 5,10-MTHF, 5,10-methylenetetrahydrofolate; MTHFR, methyltetrahydrofolate reductase; SAH, S-adenosyl homocysteine; SAM, S-adenosylmethionine; SHMT, serine hydroxymethyltransferase; THF, tetrahydrofolate; Zn, Zinc. methylation. 25 Finally, DNA methyltransferase obtains a methyl group from SAM and uses zinc as a cofactor to methylate DNA. 26 Diet-derived methyl groups are added to the cytosine residues of the cytosine-guanine (CpG) dinucleotides. 18 In mammals, CpG islands overlap with the promoter regions of many housekeeping and developmentally regulated genes and are primarily unmethylated. 27 Methylation of CpG islands near promoters can silence gene expression by inducing chromatin condensation. 27 Because most human transcription factors have CpG-rich binding sites, methylation of these regions can impede the ability of transcription factors to access the DNA, thereby inhibiting gene transcription. 27 DNA methylation is dynamic in the context of fertilization and germ-line specification; therefore, understanding the role of methyl-group donors in developmental programming in the fetus is essential.
ONE-CARBON NUTRIENT INTAKE AND DNA METHYLATION IN THE FETUS
During pregnancy, when DNA methylation patterns are being established in the fetal epigenome, nutritional influences, which alter the bioavailability and/or transfer of methyl groups to DNA, may result in permanent changes to the fetal epigenome. There are numerous examples in animal models that demonstrate the ability of the maternal diet to alter DNA methylation and gene expression patterns in the offspring. [28] [29] [30] Data from rodent studies suggest that supplementation of the maternal diet with combined extra folic acid, vitamin B 12 , betaine, and choline, 31 with or without methionine and zinc, may induce epigenetic modifications. 28 Feeding pregnant dams these methyl-supplemented diets alters the expression of their offspring's agouti genes, which encode coat color. 28 In addition, restricting folate, vitamin B 12 , and methionine intake periconceptionally in ewes resulted in a 4% change in offspring DNA methylation of certain hepatic loci when compared with the control diet. 30 Of these epigenetic changes, 88% of the DNA was unmethylated or hypomethylated, and the remainder was hypermethylated relative to controls. 30 Moreover, sex-specific phenotypic differences, whereby male offspring were observed to have greater acutephase immune response, increased fat deposition, insulin resistance, and high blood pressure, were apparent. 30 These differences may be explained by the fact that more than half of the modified loci were specific to males. Overall, data from select animal studies suggest that the maternal diet is capable of modifying DNA methylation patterns and subsequent disease risk in the offspring.
The effects of methyl-group donors on methylation and gene expression patterns in humans are less understood because the evidence remains largely unsubstantiated. In one of the rare studies performed in humans, 59 women from Gambia aged 17-45 years were given a micronutrient supplement, United Nations International Multiple Micronutrient Preparation (UNIMMAP), which contained 15 vitamins and minerals and was specifically formulated for pregnancy (folic acid, zinc, vitamins B 2 , B 6 , and B 12 , etc), or a placebo periconceptionally. 32 After pregnancy was confirmed, all women were switched to tablets containing 60 mg of elemental iron and 250 mg of folic acid. 32 When compared with the placebo group, offspring born to women who received the UNIMMAP supplement had altered expression of certain genes (21 in females and 14 in males), some of which are involved in the development of the nervous and skeletal systems (NRN1L, MEOX1) and could, therefore, affect growth. 32 Results from the Maternal Nutrition and Offspring's Epigenome cohort of mother-infant pairs in Belgium demonstrated that periconceptional methyl donor consumption (folate, folic acid, betaine) may epigenetically alter genes related to growth (IGF2, DMR), metabolism (RXRA), and appetite control (LEP) in the offspring. 33 In fact, prepregnancy folate intake and second trimester betaine and folate intake were inversely associated with LEP methylation in buccal cells in infants aged 6 months 33 and in cord blood, 34 respectively. Because LEP produces the hormone leptin, which is involved in regulating appetite suppression and fetal neural development, changes in its expression may affect susceptibility to obesity and metabolic syndrome in adulthood. 35 Although the effect of varying patterns of dietary methyl donor intake during pregnancy and their impact on epigenotype to phenotype pathways are not clearly understood, there is mounting evidence to demonstrate that one-carbon metabolism is affected by diet during pregnancy and can have long-term effects on health by altering fetal growth and development.
ONE-CARBON NUTRIENT INTAKE AND DNA METHYLATION IN THE PLACENTA
In addition to altering DNA methylation patterns in the fetus, dietary methyl donor intake during pregnancy may also influence methylation patterns in the placenta. The principal factor determining intrauterine growth rate is the supply of nutrients from the placenta to the fetus, which depends on placental morphology, size, and blood supply. 36 Maternal undernutrition, specifically inadequate protein intake, may lead to decreased placental weight and efficiency and, consequently, to reduced birth weight and intrauterine growth restriction (IUGR). 37 A recent in vitro study demonstrated increased expression of growth-promoting genes SNRPN and PEG10 in placental cells with folic acid supplementation in the physiological range of 400-600 mg/day.
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A study conducted in mice observed 460 differentially expressed placental genes and greater fetal weight among male offspring in the low maternal folic acid group (0.4 mg/kg diet) but no differences in placental weight or placental efficiency compared with the control group (2 mg/kg diet). 39 A similar study conducted in rats examined the effect of high maternal folic acid supplementation on placental methylation and expression of the gene HSD11B2, which encodes a key enzyme regulating fetal exposure to glucocorticoids. 40 In male rats, high maternal folic acid intake (8 mg/kg diet) induced a reduction in messenger RNA (mRNA) and an increase in protein levels in placentas compared with controls (1 mg/kg diet); however, no differences in birth weight were observed. 40 In females, despite no differences in mRNA or protein concentrations, offspring born to mothers in the high folic acid group had slightly higher methylation levels at 1 CpG site, 8% lower placental weight, and 6% higher birth weight. 40 Therefore, low folic acid intake and high folic acid intake during pregnancy appear to alter placental methylation patterns, placental weight, and birth weight in a sex-specific manner. Whether other one-carbon nutrients are capable of inducing epigenetic effects in the placenta and subsequently affecting the placenta's functions has been largely understudied but is worth further investigation.
ASSOCIATIONS BETWEEN INDIVIDUAL ONE-CARBON NUTRIENTS AND FETAL GROWTH
Nutritional methyl-group donors have been studied in the context of pregnancy, and extreme intakes of these nutrients may play crucial roles in fetal growth, both directly and indirectly, by altering DNA methylation patterns in the fetus and placenta. 30, 40 Folic acid, vitamin B 12 , betaine, choline, and methionine are involved in one-carbon metabolism, and their nutritional/supplemental intake during pregnancy is critical to epigenetic programming and fetal growth and development.
Folic acid
Natural sources of food folate include dark green leafy vegetables, fruits, nuts, beans, and peas, whereas folic acid, the synthetic form, is used as a fortificant in white flour, pasta, cornmeal, ready-to-eat cereals, and dietary supplements. 41 Folic acid fortification occurs in numerous countries worldwide, including Canada, the United States, and nearly all of Latin America. 42 The synthetic form has a greater bioavailability than dietary folate and is rapidly absorbed across the intestine. 43 In fact, folic acid is equivalent to 1.7 times natural folate if consumed with food and 2 times natural folate if consumed on an empty stomach. 43 Therefore, dietary folate equivalent, the weighted sum of the natural and synthetic forms, is used as a measure of folate and folic acid intake. 44 Folate is a key micronutrient required for the rapid proliferation of cells, which is essential to fetal growth and development, in addition to the healthy development of the placenta and maternal adaptation to pregnancy (ie, increased maternal blood volume). 45 Folate is vital for the growth of the spine, brain, and skull of the fetus, particularly throughout the first 4 weeks of pregnancy. 46 Moreover, the importance of folic acid in preventing neural tube defects (NTDs) is well established, 47 and since 1998, white flour, pasta, cornmeal, and cereals have been fortified with folic acid in North America. 48, 49 Since fortification began, a significant reduction in the prevalence of NTDs has been observed. 50, 51 The Institute of Medicine's Food and Nutrition Board (USA) and Health Canada issued dietary reference intakes (DRIs) for folate intake during pregnancy, with recommended daily consumption between 600 mg and 1000 mg.
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Folic acid appears to be crucial for numerous physiological functions during placental development, including cell proliferation, extravillous trophoblast invasion, and angiogenesis. 52 In fact, maternal folate deficiency is associated with placental abruption and abnormal patterning during murine placentation. 53 In mice, folic acid supplementation during pregnancy exerts anti-inflammatory effects and protects against lipopolysaccharide-induced activation of inflammatory compounds in the placenta, thereby protecting against preterm delivery and IUGR. 54 Therefore, periconceptional folic acid supplementation may be important in preventing placenta-mediated disorders that result in preterm birth and growth restriction. Systematic reviews and meta-analyses have confirmed the presence of growth restriction and/or small babies born to women with low folate levels and the importance of maternal folate (ie, folate and folic acid) intake during pregnancy for optimal birth weight. 55, 56 Additionally, serum and cord-blood concentrations of folate have proven to be important predictors of fetal growth and birth weight. 57, 58 However, the relationship between folate consumption and fetal growth is conflicting because maternal folate levels have been linked to higher birth weight in some studies [57] [58] [59] [60] but to lower birth weight in 1 study, 61 whereas others found no associations. [62] [63] [64] [65] Maternal folic acid consumption has been associated with higher birth weight, 40 lower body weight, and reduced femoral area in female rats 66 and higher birth weight in humans 67, 68 ; yet, other studies have found no associations with anthropometric measures at birth. 69, 70 Overall, the relationship between maternal folate consumption and birth weight is suggestive of a threshold effect, whereby excessive consumption of folate would have no benefit in promoting optimal birth weight.
Despite the well-defined success of folic acid in preventing NTDs, 47 concerns have been raised regarding population-wide excess folate status, with the greatest increase observed in pregnant women. 71 Several studies conducted in North America observed very high folate intake or circulating concentrations (>1360 nmol/L) in women who consumed prenatal supplements containing folic acid. [72] [73] [74] [75] [76] In fact, the mean and median intakes of folate in pregnant women in North America is above the tolerable upper intake level of 1000 mg, which is attributable to prenatal supplement and fortified food consumption. [72] [73] [74] [75] Prenatal folic acid exposure in humans is associated with a higher methylation level of IGF2, a gene involved in early growth, 77, 78 and a lower methylation level of the imprinted gene PEG3, and transposable element LINE-1 in offspring. 78 In addition to changes in methylation patterns, maternal erythrocyte folate concentration is positively associated with higher insulin resistance and increased adiposity in children, in regards to both body fat percentage and fat mass. 79 Maternal folic acid intake is positively associated with reduced birth height, 69 eczema, 80 metabolic dysfunction, 81 respiratory illness, wheeze, 82 and asthma. 83 However, the long-term effects of high folate levels on methylation patterns and offspring health are unclear.
Vitamin B 12
Vitamin B 12 , or cobalamin, is a water-soluble vitamin that acts as a cofactor for methionine synthase and is crucial for cell multiplication during pregnancy. 84 Natural vitamin B 12 is acquired mainly from animal products such as red meat, poultry, seafood, dairy products, and eggs. 85 Cobalamin deficiency is common in pregnant women in South Asia, possibly due to a low consumption of animal products. 86 Without vitamin B 12 , folate is confined as 5-MTHF, thereby inhibiting methionine regeneration and increasing homocysteine concentration. 23 Overall, vitamin B 12 is believed to be important for neurological function, DNA synthesis, and blood formation. 87 Although the DRIs recommend that women consume 2.6 mg of vitamin B 12 daily, no tolerable upper intake level has been established for this vitamin. 85 Similar to folic acid, adequate vitamin B 12 status in pregnancy may also be important for the prevention of NTDs 88 ; however, the role of maternal vitamin B 12 in offspring birth weight is unclear. Higher maternal vitamin B 12 levels are associated with reduced global DNA methylation in newborns, whereas increased vitamin B 12 concentrations in infants are associated with decreased IGF2 methylation. 89 Several studies conducted in South Asian populations demonstrated that low maternal or neonatal vitamin B 12 concentration is associated with low birth weight, 90 IUGR, 91 and high insulin resistance in offspring at 6 years old. 79 Moreover, low maternal intake of both vitamin B 12 and folate in the first trimester is associated with a greater risk of giving birth to a small-for-gestational-age infant, although the greatest risk is in women who consume high levels of supplemental folic acid (>1000 mg) with a low vitamin B 12 to folate ratio. 61 However, South Asian infants have smaller birth weights than infants from other ethnic groups, so the rate of small-for-gestational-age babies may be overestimated when standardized cut-offs are used. 92 This may partly explain why other studies found no associations between vitamin B 12 concentration and IUGR, 93, 94 small-for-gestational-age, birth length, birth weight, gestational age at delivery, and preterm birth. 95 The use of different biomarkers and time points to assess vitamin B 12 intake and/or concentration may also contribute to the variation in results. In Canada, vitamin B 12 deficiency, when measured by holoTC (the biologically active portion of plasma vitamin B 12 ), appears to be uncommon in pregnant women with high socioeconomic status, 76 and most pregnant women consume levels above the recommended dietary allowance when taking a prenatal supplement. 73 In contrast, when total plasma vitamin B 12 was measured in pregnant women from Vancouver, Canada, deficiency and marginal deficiency were high (10% and 21%, respectively), with increasing prevalence as pregnancy progressed. 96 However, when methylmalonic acid (MMA) was used as a functional biomarker of vitamin B 12 deficiency, only 2%-5% of women had elevated MMA (>271 nmol/L). 97 Therefore, it is critical that the biomarker used to measure vitamin B 12 intake or status be specified. Although no adverse effects from excessive consumption of vitamin B 12 have been reported in women of reproductive age, it is theoretically possible that high consumption of vitamin B 12 during pregnancy may play a role in epigenetic programming of the fetus and/or placenta.
Choline and betaine
Choline is a water-soluble nutrient that can be obtained through food sources such as eggs and dairy products or synthesized by the body, but it is not found in prenatal supplements. 41 The enzyme betaine homocysteine methyltransferase uses betaine, which can be derived from choline or consumed directly from the diet, to supply a methyl group required for the conversion of homocysteine to methionine (Figure 1) . 24 This conversion is part of the the folate-independent cycle and takes place in the liver and kidney. 24 Although there was insufficient scientific evidence to set a recommended dietary allowance for choline, an adequate intake (AI) value of 450 mg/day is recommended. 44 Similar to folic acid and vitamin B 12 , choline plays an important role in brain development 98 and neural tube closure, 99 and the depletion of this nutrient results in neural cell death. 98 One study conducted in women in the United States observed the lowest NTD risk when women consumed higher daily amounts of choline (>498 mg), betaine (>258 mg), and methionine (>2492 mg) periconceptionally. 99 These findings indicate that deficiencies in one-carbon nutrients other than folic acid and vitamin B 12 may play a role in NTD risk. Despite the importance of choline intake during pregnancy, several studies demonstrated that roughly 80%-90% of women in North America consume choline at levels below the AI. 73, 100, 101 Because the risk of deficiency cannot be assessed with an AI, it is uncertain what proportion of women in North America are truly at risk of insufficient choline intake.
It is unclear whether choline or betaine play critical roles in regulating offspring birth weight. Adequate choline and betaine intake may be important to ensure optimal methyl donor intake required for developmental programming; however, studies examining umbilical cord blood and maternal concentrations of choline and betaine in relation to birth weight provided contrasting results: both low 102 and high 103 umbilical, but not maternal, concentrations were associated with low birth weight. One study in Chinese, Malay, and Indian women showed that higher maternal betaine status was associated with smaller size at birth and less abdominal fat mass. 104 Differences in the timing, source, and conditions of measurement of these 2 methyl donor concentrations (ie, second or third trimester maternal blood vs cord blood, fasting vs nonfasting samples) may partly explain the discrepancy in results. Finally, maternal choline and betaine intake in combination with other micronutrients may be important for ensuring adequate fetal growth, but more studies are required to confirm this theory.
Choline is involved in the synthesis of several biomolecules important for placental development; therefore, choline intake during pregnancy may affect placental development and vascularization. 105 In fact, supplementing the maternal diet with high doses of choline (up to 930 mg/day, which is twice the AI) decreased placental expression and circulating concentration of antiangiogenic factors, 106 increased methylation of placental cortisol-regulating genes, and reduced cortisol levels in the infant. 107 Choline insufficiency disrupts placental development in vitro by affecting angiogenesis and increasing inflammation and trophoblast apoptosis. 105 However, the roles of choline and betaine in epigenetic programming within placental and fetal tissues in vivo and how these changes may affect growth have not yet been elucidated.
Methionine
Methionine is an essential amino acid and a methylgroup donor in one-carbon metabolism. Methionine is converted into homocysteine by donating a methyl group to form SAM, which supplies the methyl groups needed for DNA methylation. 25 The amino acid, cysteine, which can be derived from the trans-sulfuration of homocysteine, is also important for growth and the synthesis of proteins. 25 Because cysteine can be formed from methionine, the DRIs for methionine are reported in conjunction with cysteine and are weight dependent. 44 During pregnancy, methionine is required for protein synthesis and, as such, adequate methionine availability is associated with normal fetal growth trajectories in humans and animals. 108, 109 Moreover, methionine intake during pregnancy may influence developmental programming in the offspring. Animal studies have shown the effect of methyl donor restriction on methionine availability, whereby piglets fed a diet deficient in betaine, choline, and folate had elevated homocysteine levels. 110 Remethylation and transmethylation were significantly (P < 0.05) reduced in these piglets as methyl donors were preferentially used in protein synthesis. 111 One study demonstrated that low methionine intake, among other amino acids, led to growth retardation in rats. 108 In humans, methionine concentration measured in amniotic fluid during the second trimester strongly predicted both birth length and weight. 109 Therefore, maternal methionine consumption may be important in developmental programming and to ensure optimal fetal growth.
Other one-carbon metabolism nutrients
In addition to folic acid, vitamin B 12 , choline, betaine, and methionine, vitamins B 2 , B 6 , and zinc are also involved in one-carbon metabolism (Figure 1) . Intake of these nutrients during pregnancy may affect fetal growth and developmental programming. However, the evidence for this is conflicting because some studies observed positive associations with vitamin B 2 112,113 and vitamin B 6 114,115 intake during pregnancy and fetal growth, yet others found no associations. 75, 116 Moreover, zinc deficiency (<56 mg/dL) during pregnancy is associated with both an increased risk of fetal growth restriction 117 and a higher mean birth weight. 118 A Cochrane review found a small risk reduction in preterm birth with maternal zinc intake; however, no convincing association was observed with birth weight. 119 Nevertheless, because one-carbon nutrients are often consumed in combination, it is important to understand the impact of groups of these nutrients on fetal growth and epigenetic regulation.
ASSOCIATIONS AMONG GROUPS OF ONE-CARBON NUTRIENTS AND FETAL GROWTH
Maternal multinutrient consumption has been shown to affect fetal growth in animals and human populations. Previous studies using an elegant porcine model showed that piglets whose mothers were supplemented with high levels (up to 400 times greater than the control group) of one-carbon nutrients (methionine, choline, folic acid, vitamin B 6 , vitamin B 12 , and zinc) during pregnancy had significantly (P < 0.05) greater fetal weights at mid to late gestation when compared with age-matched controls. 120 Despite no significant (P > 0.05) difference in birth weights between the 2 groups, postnatal live weight was greater in supplemented compared with control males. 120 In addition, offspring born to the highly supplemented sows exhibited a greater abundance of transcripts associated with growth, myogenesis, lipid and energy metabolism, and IGF signaling compared with control piglets. 120 One study conducted in Burkina Faso, Africa, found that women who consumed the UNIMMAP supplement prenatally gave birth to infants who were 69 g larger and 4 mm longer, on average, and had greater midupper arm and thoracic circumference than infants born to mothers consuming folic acid and iron only. 121 Women who received the UNIMMAP supplement were also more likely to give birth to a large-for-gestationalage infant than women who consumed folic acid and iron only. 121 Few studies have examined the epigenetic effect of multivitamins on fetal growth and development in animals [122] [123] [124] or humans. 125, 126 Overall, further research is needed to examine the potential effects of these dietary methyl donors and cofactors on fetal health outcomes.
LIFELONG HEALTH IMPACTS OF ONE-CARBON NUTRIENT INTAKE DURING PREGNANCY
Nutritional intake of dietary methyl donors during pregnancy can modify DNA methylation patterns in the fetal epigenome, thereby affecting fetal growth and the risk of several diseases in adulthood. Although the field of fetal programming is relatively underdeveloped, research has shown that aberrations in the maternal diet can have lasting effects on the offspring, as demonstrated by associations with cancer, 127 insulin resistance, 30 and obesity. 122, 128 In mice, maternal diets low in methyl donors led to hypomethylation of the agouti gene, 28 which predisposed offspring to obesity, hyperinsulinemia, diabetes, increased somatic growth, susceptibility to hyperplasia, and tumorigenesis. 129 High vitamin intake during pregnancy altered hypothalamic gene expression and predisposed rat offspring to an obesogenic phenotype: greater food intake, adiposity, leptin concentration, and glucose intolerance. 122 Moreover, a reduction in folate, vitamin B 12 , and methionine at the time of conception led to epigenetic modifications associated with greater insulin resistance, adiposity, high blood pressure, and altered immune systems in adult sheep offspring. 30 Overall, few studies have examined the relationship between methyl donor-induced epigenetic effects during pregnancy and adulthood disease risk in humans. Although challenging, this area of research is ripe for further investigation.
CONCLUSION
Current research indicates that both insufficient and high one-carbon nutrient intake during pregnancy affect the fetal and placental epigenome, in utero growth, and offspring birth weight. Animal studies have shown that methyl donor intake may alter methylation patterns in the fetus and placenta, thereby influencing the risk for several diseases in later life. Nevertheless, the scientific evidence is conflicting, particularly for consumption in humans, because high intake of one-carbon nutrients before and during pregnancy is associated with both hypo-and hypermethylation in the offspring. Epidemiological studies have determined maternal concentrations of one-carbon nutrients from food, supplements, and blood at different time points in pregnancy and examined the associations with methylation patterns in different sources of genomic DNA (ie, cord blood, tissue) in the offspring. Moreover, the use of different cell types and loci under study yield different DNA methylation profiles and results. Although most women in North America consume high amounts of some dietary methyl donors during pregnancy, many women in developing countries may not consume adequate amounts. Therefore, understanding the potential effects on the fetus and predisposition to disease is crucial. Future research should focus on elucidating the relationship among varying patterns of one-carbon nutrient intake during pregnancy, epigenetic effects of one-carbon nutrient intake, and subsequent adulthood health outcomes in the offspring.
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